Sold as Dimetane, Dimetane-Ten. Every FDA application for this active ingredient: 2 branded and 20 generic.
As of Nov 16, 2026, FDA lists 22 applications for Brompheniramine Maleate (sold as Dimetane, Dimetane-Ten), first approved Aug 23, 1957, with 1 new use approved and 0 published complete response letters.
| Study | Phase | Status | Posted |
|---|---|---|---|
| Metronomic Temozolomide With Dexbrompheniramine for Recurrent High-Grade Glioma/GlioblastomaHigh Grade Glioma, Glioblastoma · University of Nebraska | Phase 1 / Phase 2 | Not yet recruiting | Oct 5, 2026 |
| Aug 23, 1957 | DimetaneNDA 10799 · New formulation or manufacturer | Wyeth Cons | 21 | Discontinued |
| Sep 29, 1958 | Dimetane-TenNDA 11418 · New dosage form | Wyeth Ayerst | 13 | Discontinued |
| May 17, 1974 | VeltaneANDA 84088 | Lannett | 0 | Marketed |
| Apr 7, 1975 | Brompheniramine MaleateANDA 84468 | Barr | 0 | Discontinued |
| Dec 17, 1975 | Brompheniramine MaleateANDA 84351 | Ivax Sub Teva Pharms | 0 | Discontinued |
| Dec 19, 1975 | Brompheniramine MaleateANDA 83215 | Upsher Smith Labs | 5 | Discontinued |
| May 20, 1976 | Brompheniramine MaleateANDA 83821 | Watson Labs | 18 | Discontinued |
| Nov 15, 1976 | Brompheniramine MaleateANDA 83123 | Watson Labs | 0 | Discontinued |
| Aug 19, 1977 | Brompheniramine MaleateANDA 85466 | Kv Pharm | 0 | Discontinued |
| Apr 26, 1978 | Brompheniramine MaleateANDA 85888 | Pvt Form | 0 | Discontinued |
| Aug 24, 1978 | Brompheniramine MaleateANDA 86187 | Nexgen Pharma Inc | 0 | Discontinued |
| Oct 26, 1979 | Brompheniramine MaleateANDA 86987 | Newtron Pharms | 0 | Discontinued |
| Jul 16, 1981 | Brompheniramine MaleateANDA 86936 | Alpharma US Pharms | 3 | Discontinued |
| Jan 25, 1983 | Brompheniramine MaleateANDA 87964 | Usl Pharma | 2 | Discontinued |
| — | Brompheniramine MaleateANDA 83820 | Watson Labs | 0 | Discontinued |
| — | Brompheniramine MaleateANDA 85521 | Phoenix Labs Ny | 0 | Marketed |
| — | Brompheniramine MaleateANDA 85592 | Nylos | 0 | Marketed |
| — | Brompheniramine MaleateANDA 85769 | Watson Labs | 1 | Discontinued |
| — | Brompheniramine MaleateANDA 85850 | Vitarine | 0 | Discontinued |
| — | Brompheniramine MaleateANDA 87009 | Par Pharm | 0 | Discontinued |
| — | Brompheniramine MaleateANDA 87517 | Pharm Assoc | 0 | Discontinued |
| — | Brompheniramine MaleateANDA 88604 | Pioneer Pharms | 0 | Discontinued |
Applications, approvals and products come from FDA's Drugs@FDA data files, refreshed weekly, grouped by active ingredient as FDA spells it. Complete response letters are FDA's published letters. Medicare spending is CMS's Part D and Part B dashboard, matched to this ingredient by generic name; shortages are FDA's shortage list, matched by application number; clinical trials are ClinicalTrials.gov studies naming the ingredient as an intervention, refreshed daily; safety programs are FDA's REMS list, matched by application number or, for shared programs, by ingredient. Drugs@FDA